Regenxbio (RGNX) Revenue Growth (1y) (2015 - 2025)
Regenxbio (RGNX) Revenue Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.57 Bn | 466.77 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.01 Bn | 114.76 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 96.43% |
| 10 | Regenxbio | 505.42 Mn | 275.35 Mn | 21.22 Mn | 27.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.97% |
| Sep 30, 2025 | 22.88% |
| Jun 30, 2025 | -2.23% |
| Mar 31, 2025 | 467.32% |
| Dec 31, 2024 | -4.50% |
| Sep 30, 2024 | -16.31% |
| Jun 30, 2024 | 9.36% |
| Mar 31, 2024 | -19.82% |
| Dec 31, 2023 | -29.13% |
| Sep 30, 2023 | 9.06% |
| Jun 30, 2023 | -38.81% |
| Mar 31, 2023 | -13.86% |
| Dec 31, 2022 | -92.14% |
| Sep 30, 2022 | -13.85% |
| Jun 30, 2022 | 48.17% |
| Mar 31, 2022 | 17.66% |
| Dec 31, 2021 | 1,758.96% |
| Sep 30, 2021 | -68.89% |
| Jun 30, 2021 | 33.01% |
| Mar 31, 2021 | 7.03% |